| Category: |
siRNA |
| Antibody's target: |
BRCA2 |
| Immunogen: |
See techfile |
| The antibody was raised in: |
Synthetic |
| Reactivity: |
Mouse, Rat, Human |
| Purification: |
Affinity purified |
| Applications: |
WB (for other see techfile or inquire) |
| Stock availability: |
Shipped within 5-10 working days |
| Storage conditions: |
Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C |
| Warnings: |
This product is for research use only |
| Gene target: |
BRCA2 siRNA |
| Short name: |
Anti-BRCA2 siRNA |
| Alternative name: |
early onset small interfearing RNA, antibody to-breast cancer 2 |
| Alternative to gene target: |
BRCA2 and IDBG-22703 and ENSG00000139618 and 675, BRCA2 and IDBG-630223 and ENSBTAG00000000988 and, BRCC2 and BROVCA2 and FACD and FAD and FAD1 and FANCD and FANCD1 and GLM3 and PNCA2, Brca2 and IDBG-209587 and ENSMUSG00000041147 and 12190, DNA-templated and biological process this GO :0045931 and positive regulation of mitotic cell cycle and biological process this GO :0048478 and replication fork protection and biological process this GO :0051276 and chromosome organization and biological process this GO :0051298 and centrosome duplication and biological process, early onset, gamma-tubulin binding, nuclei, signal transduction by p53 class mediator resulting in transcription of p21 class mediator and biological process this GO :0007141 and male meiosis I and biological process this GO :0007283 and spermatogenesis and biological process this GO :0007420 and brain development and biological process this GO :0007569 and cell aging and biological process this GO :0008283 and cell proliferation and biological process this GO :0008585 and female this GO nad development and biological process this GO :0008630 and intrinsic apoptotic signaling pathway in response to DNA damage and biological process this GO :0010165 and response to X-ray and biological process this GO :0010225 and response to UV-C and biological process this GO :0010332 and response to gamma radiation and biological process this GO :0010484 and H3 histone acetyltransferase activity and molecular function this GO :0010485 and H4 histone acetyltransferase activity and molecular function this GO :0030097 and hemopoiesis and biological process this GO :0030141 and secretory granule and cellular component this GO :0032465 and regulation of cytokinesis and biological process this GO :0033593 and BRCA2-MAGE-D1 complex and cellular component this GO :0033600 and negative regulation of mammary gland epithelial cell proliferation and biological process this GO :0042771 and intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator and biological process this GO :0043009 and chordate embryonic development and biological process this GO :0043015 and gamma-tubulin binding and molecular function this GO :0043234 and protein complex and cellular component this GO :0043966 and histone H3 acetylation and biological process this GO :0043967 and histone H4 acetylation and biological process this GO :0045893 and positive regulation of transcription, this GO :0000724 and double-strand break repair via homolo this GO us recombination and biological process this GO :0000910 and cytokinesis and biological process this GO :0001556 and oocyte maturation and biological process this GO :0001833 and inner cell mass cell proliferation and biological process this GO :0002020 and protease binding and molecular function this GO :0003697 and single-stranded DNA binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005813 and centrosome and cellular component this GO :0006281 and DNA repair and biological process this GO :0006289 and nucleotide-excision repair and biological process this GO :0006302 and double-strand break repair and biological process this GO :0006974 and cellular response to DNA damage stimulus and biological process this GO :0006978 and DNA damage response, this GO :0002020 : protease binding, this GO :0002020 : protease binding and also this GO :0003697 : single-stranded DNA binding and also this GO :0005515 : protein binding and also this GO :0010484 : H3 histone acetyltransferase activity and also this GO :0010485 : H4 histone acetyltransferase activity and also this GO :0043015 : gamma-tubulin binding, this GO :0003697 : single-stranded DNA binding, this GO :0005515 : protein binding, this GO :0010484 : H3 histone acetyltransferase activity, this GO :0010485 : H4 histone acetyltransferase activity, this GO :0043015 : gamma-tubulin binding, breast cancer 2 |
| Identity: |
1101 |
| Gene: |
BRCA2 |
More about : BRCA2 |
| Long gene name: |
BRCA2, DNA repair associated |
| Synonyms gene: |
FANCD1 FACD FANCD |
| Synonyms gene name: |
Fanconi anemia, complementation group D1 breast cancer 2, early onset breast cancer 2 |
| Synonyms: |
FAD FAD1 BRCC2 XRCC11 |
| Synonyms name: |
BRCA1/BRCA2-containing complex, subunit 2 |
| Locus: |
13q13, 1 |
| Discovery year: |
1994-10-17 |
| GenBank acession: |
U43746 |
| Entrez gene record: |
675 |
| Pubmed identfication: |
8091231 7581463 15057823 |
| RefSeq identity: |
NM_000059 |
| Classification: |
Fanconi anemia complementation groups |
| Havana BLAST/BLAT: |
OTTHUMG00000017411 |
| Locus Specific Databases: |
Breast Cancer Fanconi Anaemia Mutation Database BRCA1 database at LOVD-China LOVD - Leiden Open Variation Database LOVD - Leiden Open Variation Database Fanconi anemia database LRG_293 |